Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders -A retrospective tolerability and safety study

被引：0
|
作者：
Iser, C. [1 ]
Anderson, C. [1 ]
Hirte, I [1 ]
Boddu, S. [1 ]
Girardo, M. [1 ]
Joseph, A. [1 ]
VanderPluym, J. [1 ]
Starling, A. [1 ]
机构：
[1] Mayo Clin, Scottsdale, AZ USA
来源：
HEADACHE | 2023年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-177
引用
收藏
页码：31 / 32
页数：2
相关论文
共 50 条
  • [1] Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders-A retrospective tolerability and safety study
    Anderson, Christopher C.
    Iser, Courtney R.
    Hirte, Ingrid L.
    Boddu, Sayi
    Girardo, Marlene E.
    Vanderpluym, Juliana H.
    Starling, Amaal J.
    HEADACHE, 2024, 64 (06): : 663 - 673
  • [2] Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine
    Diener, H. -C.
    Dodick, D. W.
    Turkel, C. C.
    Demos, G.
    DeGryse, R. E.
    Earl, N. L.
    Brin, M. F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (06) : 851 - 859
  • [3] Peripheral Nerve Blocks for the Treatment of Headache in Older Adults: A Retrospective Study
    Hascalovici, Jacob R.
    Robbins, Matthew S.
    HEADACHE, 2017, 57 (01): : 80 - 86
  • [4] A Review of "Peripheral Nerve Blocks for the Treatment of Headache in Older Adults: A Retrospective Study"
    Krasenbaum, Lynda J.
    HEADACHE, 2017, 57 (01): : 128 - 128
  • [5] Effectiveness and tolerability of greater occipital nerve blocks for the prophylactic treatment of cluster headache - A retrospective study
    Balvers, Tijmen
    Doesborg, Patty
    Meilof, Roy
    Bartels, Evelien
    Ferrari, Michel
    Fronczek, Rolf
    CEPHALALGIA, 2017, 37 : 219 - 220
  • [6] Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: Results of the COMPEL Study
    Paul K. Winner
    Andrew M. Blumenfeld
    Eric J. Eross
    Amelia C. Orejudos
    Debbie L. Mirjah
    Aubrey Manack Adams
    Mitchell F. Brin
    Drug Safety, 2019, 42 : 1013 - 1024
  • [7] Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: Results of the COMPEL Study
    Winner, Paul K.
    Blumenfeld, Andrew M.
    Eross, Eric J.
    Orejudos, Amelia C.
    Mirjah, Debbie L.
    Adams, Aubrey Manack
    Brin, Mitchell F.
    DRUG SAFETY, 2019, 42 (08) : 1013 - 1024
  • [8] OnabotulinumtoxinA for Chronic Migraine: Safety and Tolerability of the Effective Treatment Paradigm in the PREEMPT Clinical Program
    Aurora, S. K.
    Dodick, D. W.
    Blumenfeld, A.
    DeGryse, R. E.
    Turkel, C. C.
    HEADACHE, 2010, 50 : S14 - S15
  • [9] The Utility of Repeat Peripheral Nerve Blocks in the Treatment of Chronic Daily Headache
    Guay, M.
    Lay, C.
    Lagman-Bartolome, A.
    HEADACHE, 2023, 63 : 174 - 175
  • [10] OnabotulinumtoxinA for the preventive treatment of chronic migraine in older adults: A retrospective study
    Soh, P.
    Grosberg, B. M.
    Verhaak, A.
    HEADACHE, 2022, 62 : 153 - 154
12345